Local regulation of [(3)H]-noradrenaline release from the isolated guinea-pig right atrium by P(2X)-receptors located on axon terminals

Br J Pharmacol. 2000 Dec;131(8):1775-83. doi: 10.1038/sj.bjp.0703757.

Abstract

In this study the regulation of cardiac sympathetic outflow by presynaptic P(2X) receptor-gated ion channels was examined. ATP (30 microM - 1 mM) and other P2-receptor agonists elicited [(3)H]-noradrenaline ([(3)H]-NA) outflow from the isolated guinea-pig right atrium with the potency order of ATP>2-methyl-thioATP>alpha,beta-methylene-ATP=ADP, whereas ss, gamma-methylene-L-ATP was inactive. Ca(2+)-free conditions abolished both electrical field stimulation (EFS)- and ATP-evoked release of tritium. Unlike from EFS-induced outflow, ATP-induced [(3)H]-NA outflow was not reduced by omega-Conotoxin-GVIA (100 nM), Cd(2+) (100 microM) and tetrodotoxin (1 microM). The rapid extracellular decomposition of ATP was revealed by HPLC analysis. However, the effect of ATP to promote [(3)H]-NA release was not prevented by 8-cyclopentyl-1,3-dipropylxanthine (DPCPX, 250 nM), 3, 7-dimethyl-1-propargylxanthine (DMPX, 250 nM), or by reactive blue 2 (RB2, 10 microM), antagonists of A(1)-, A(2)- and inhibitory P(2) receptors. Zn(2+) (50 microM), the P(2X)-receptor modulator potentiated, and P(2X) receptor antagonists, i.e. suramin (300 microM), pyridoxal-phosphate-6-azophenyl-2',4'-disulphonic acid (PPADS, 30 microM) and 2'-o-(trinitrophenyl)-adenosine 5'-triphosphate (TNP-ATP, 30 microM) antagonized the ATP (1 mM)-evoked response. RT - PCR study revealed the expression of P(2X2) and P(2X3) receptor mRNAs in guinea-pig superior cervical ganglion. PPADS (30 microM) significantly reduced the EFS-induced [(3)H]-NA outflow in the presence DPCPX (250 nM) and RB2 (10 microM). In summary a P(2X)-type purinoceptor regulates noradrenaline release from the isolated right atrium of the guinea-pig. The pharmacological profile of the receptor resemble to homo-oligomeric P(2X3) or hetero-oligomeric P(2X2)/P(2X3) complexes, and provide a new target to intervene on sympathetic neuroeffector transmission at the presynaptic site.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Diphosphate / pharmacology
  • Adenosine Triphosphate / analogs & derivatives*
  • Adenosine Triphosphate / pharmacology
  • Animals
  • Cadmium / pharmacology
  • Dose-Response Relationship, Drug
  • Electric Stimulation
  • Gene Expression
  • Guinea Pigs
  • Heart Atria / drug effects
  • Heart Atria / metabolism*
  • Hippocampus / metabolism
  • In Vitro Techniques
  • Male
  • Norepinephrine / metabolism*
  • Presynaptic Terminals / physiology*
  • Purinergic P2 Receptor Agonists
  • Purinergic P2 Receptor Antagonists
  • Pyridoxal Phosphate / analogs & derivatives*
  • Pyridoxal Phosphate / pharmacology
  • RNA / genetics
  • RNA / metabolism
  • Receptors, Purinergic P2 / physiology*
  • Superior Cervical Ganglion / metabolism
  • Tetrodotoxin / pharmacology
  • Theobromine / analogs & derivatives*
  • Theobromine / pharmacology
  • Thionucleotides / pharmacology
  • Time Factors
  • Tritium
  • Xanthines / pharmacology
  • omega-Conotoxin GVIA / pharmacology

Substances

  • Purinergic P2 Receptor Agonists
  • Purinergic P2 Receptor Antagonists
  • Receptors, Purinergic P2
  • Thionucleotides
  • Xanthines
  • Cadmium
  • Tritium
  • pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid
  • 5'-adenylyl (beta,gamma-methylene)diphosphonate
  • Tetrodotoxin
  • Pyridoxal Phosphate
  • 3,7-dimethyl-1-propargylxanthine
  • Adenosine Diphosphate
  • RNA
  • Adenosine Triphosphate
  • omega-Conotoxin GVIA
  • 1,3-dipropyl-8-cyclopentylxanthine
  • alpha,beta-methyleneadenosine 5'-triphosphate
  • Theobromine
  • Norepinephrine
  • 2-methylthio-ATP